epitope corresponding to amino acids 1-146 representing full length CDD of human origin
Modification Notes
Cytidine deaminase (CDD or CDA) is a member of the cytidine and deoxycytidylate deaminase family of proteins. CDD catalyzes the deamination of chemotherapeutic cytosine nucleoside analogs such as Ara-C and 5-azacytidine, which results in the loss of their cytotoxic and antitumor function. Ara-C is used in the treatment of acute myeloid leukemia (AML), and the antileukemic activity of the drug is contingent on phosphorylation by deoxycytidine kinase (DCK). Resistance to Ara-C is a major determinant of unsucessful AML treatment, the failure of which has been attributed to a DCK functional defect and increased CDD activity. CDD also scavenges endogenous and exogenous cytidine and 2’-deoxycytidine for UMP synthesis. CDD can form homotetramers and is mainly expressed in granulocytes.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of CDD (Cytidine deaminase) of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including equine:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 1-146 representing full length CDD of human origin
Tissue Specificity
epitope corresponding to amino acids 1-146 representing full length CDD of human origin
Western blot analysis of CDD expression in non-transfected 293T: (A), human CDD transfected 293T: (B) and DU 145 (C) whole cell lysates.
Application Notes
recommended for detection of CDD (Cytidine deaminase) of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including equine:
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.